Technology

Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.

Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma

So far companies have only scratched the surface of the potential offered by the 'new mobile ecosystem', writes Neeraj Singhal.

For a rendering to be effective, the right balance must be struck between captivating art and accurate science.

Forget illegal immigrants, it is machines that are stealing American jobs. For some medical practice areas, however, digital details haven’t sufficiently stepped in where their human sales rep predecessors have stepped (or have been pushed) out, according to a survey of U.S. physicians.

A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.

The time is right for industry to overcome its social media phobia once and for all.

Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.

Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed

It's a work in progres among EHR providers to offer a clear bridge between pharma and physicians.

Is Google+ the social media platform that pharma has been waiting for?

'Like' and 'Dislike' practices in the virtual Facebook pharmaceutical world.

NeHC's new Consumer Consortium is promoting a new stakeholder agenda to improve patient knowledge

A federal appeals court has lifted a ban on federal funding for embryonic stem cell research.

Online sentiment analysis monitoring can help biopharma resource managers make crucial decisions

The sleek, portable iPad, coupled with customized apps, gives sales reps a leg up

A factory tour to examine Merck's automated robots-and the human minds that inspire them

The pharmaceutical industry needs to use new and better data to accurately measure how much it is willing to invest in avoiding plan control

How to achieve distribution diversification in a small market

New CER tools grant payers the evidence they need to control drug costs

The FDA process itself is looking more like the unsavory 'sausage factory' associated with drafting partisan legislation

Will Roche's precedent push the regulatory community to create standards that will level the playing field for all contenders?

The new world of mobile applications is sparking creative platforms for reaching consumers and physicians.

As 2009 gets started and a new president takes office, the Biopharma industry is left wondering if Obama will be a friend or foe when it comes to healthcare information technology.